Lv11
54 积分 2024-05-21 加入
Early detection of dopaminergic dysfunction and glymphatic system impairment in Parkinson's disease
5小时前
已完结
Machine Learning-Based Dose Prediction in [177Lu]Lu-PSMA-617 Therapy by Integrating Biomarkers and Radiomic Features from [68Ga]Ga-PSMA-11 PET/CT
13天前
已关闭
Dosimetry in Lu-177-PSMA-617 prostate-specific membrane antigen targeted radioligand therapy: a systematic review
13天前
已完结
A systematic review on artificial intelligence evaluating PSMA PET scan for intraprostatic cancer
15天前
已完结
68Ga-PSMA PET/CT for monitoring response to 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
19天前
已完结
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria
19天前
已完结
Prognostic value of [18F]FDG- and PSMA-PET in patients evaluated for [177Lu]Lu-PSMA therapy of mCRPC
19天前
已完结
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study
20天前
已完结
Long-term survival outcomes of salvage [225Ac]Ac-PSMA-617 targeted alpha therapy in patients with PSMA-expressing end-stage metastatic castration-resistant prostate cancer: a real-world study
20天前
已完结
225Ac-PSMA-617 for Therapy of Prostate Cancer
20天前
已完结
皖公网安备34019202002308
